What you should know:
1. The alliance aims to be a leading voice on musculoskeletal biologics and regenerative medicine.
2. The alliance was founded in 2018 to evaluate current guidance around biologics-based treatments. They aim to advocate for the responsible use of biologics by developing a scientific basis for the treatments.
The alliances’ board is led by the following leading voices in the orthopedics community:
- Brian Cole, MD, of Chicago-based Rush University
- Jason Dragoo, MD, of Denver-based University of Colorado
- Christian Lattermann, MD, of Boston-based Brigham and Women’s Hospital
- Bert Mandelbaum, MD, of Los Angeles-based Cedars-Sinai Kerlan-Jobe Institute
- Louis McIntyre, MD, of Hempstead, N.Y.-based Hofstra University
- Norimasa Nakamura, MD, of Osaka University Hospital in Japan
- Scott Rodeo, MD, of New York City-based Hospital for Special Surgery
- John Tokish, MD, of Phoenix-based Mayo Clinic Arizona
- Ken Zaslav, MD, of Lynchburg-based OrthoVirginia
More articles on healthcare:
Orthofix’s M6-C cervical disc in 2019: 7 key developments
Dr. Robert Brady: How the 2020 CMS final rule will affect the spine field
How OrthoNY is trying to solve its recruiting problem
